Effect of a JAK inhibitor on gene expression of HUT78 cell line
收藏官方服务：
资源简介：
Effect of a JAK inhibitor on gene expression of HUT78 cell line
应用场景：
创建时间：
2015-10-31
相关数据集
A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis.
A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis. CR – complete response; NCR – near complete response; PR – partial response.
NIAID Data Ecosystem30
Oral Janus Kinase Inhibitors in Pediatric Vitiligo: A Real-World Retrospective Cohort Study
Supplementary Figure 1 shows the percentage of improvement in facial VASI scores over treatment time for all patients. Supplementary Figure 2 shows the percentage of improvement in trunk VASI scores o
Mendeley Data10
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results. Supplementary Figures and Tables
Supplementary Figures 1-7. Supplementary Tables 1-5
NIAID Data Ecosystem10
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy Phase 3 trial in the United States and Canada (BREEZE-AD5) - Supplement
Background: Baricitinib, an oral, selective Janus kinase (JAK)1/JAK2 inhibitor, is being studied for moderate-to-severe atopic dermatitis (AD) in adults. Objective: To evaluate the efficacy and safe
NIAID Data Ecosystem20
Real-world experience of JAK Inhibitors in eyebrow regrowth for alopecia areata: a retrospective single-center study
It details a retrospective single-center study evaluating the real-world efficacy of oral JAK inhibitors, including ritlecitinib, tofacitinib, and baricitinib, for eyebrow regrowth in 74 patients with
NIAID Data Ecosystem10
